Medetomidine, a Pet Sedative, Spreads in U.S. Illegal Drug Supply

Key TakeawaysMedetomidine, a sedative for animals, is turning up in illegal drugsThe drug may make opioid overdoses harder to reverseIt caused large overdose clusters in Chicago, Philadelphia and Pittsburgh.FRIDAY, May 2, 2025 (HealthDay News) — A sedative used in animals is showing up more often in illegal drugs and may be making opioid overdoses harder to treat, U.S. health officials warn.The drug, called medetomidine, is used by veterinarians to sedate pets. It's similar to xylazine, another animal drug that has already made the U.S. opioid crisis worse, The Associated Press reported.Now, medetomidine is being found mixed with fentanyl and other street drugs, the U.S. Centers for Disease Control and Prevention (CDC) stated.The CDC released three reports showing how the drug is spreading in cities like Chicago, Philadelphia and Pittsburgh.In Chicago last May, officials noticed a spike in overdoses. Naloxone, the usual treatment for fentanyl overdose, wasn’t working well.After an investigation, 12 cases were confirmed to involve medetomidine, and more than 160 others were considered likely cases, including one possible death.In Philadelphia, medetomidine was found in 72% of illegal opioid samples tested late last year, AP reported.That was more than xylazine, which had been a growing concern in recent years.More than 160 people in the city were hospitalized with a strange kind of withdrawal that did not respond to usual treatments. But doctors found that another medication, dexmedetomidine, worked.Pittsburgh also saw 10 similar cases around the same time.More informationScience Direct has more on medetomidine.SOURCE: The Associated Press, May 1, 2025.What This Means For YouA new drug in the U.S. illegal drug supply, the pet sedative medetomidine, could make overdoses harder to reverse..Sign up for our weekly HealthDay newsletter

Medetomidine, a Pet Sedative, Spreads in U.S. Illegal Drug Supply

Related Stories

3 Common Drugs Older Adults Might Be Overusing

Cardiologists Expected This New Drug To Prevent Heart Attacks — So Why Did It Fail?

FDA Approves New Pill For Advanced Breast Cancer Guided By Blood Test

Extreme Heat Linked to 33 Clinically Reportable Diagnoses